Catheter Ablation of Atrial Fibrillation

Thomas D. Callahan IV; Luigi Di Biase; Rodney Horton; Javier Sanchez; Joseph G. Gallinghouse; Andrea Natale

doi:10.1016/j.ccl.2008.09.004

Catheter Ablation of Atrial Fibrillation

Thomas D. Callahan IV, Luigi Di Biase, Rodney Horton, Javier Sanchez, Joseph G. Gallinghouse, Andrea Natale

Research output: Contribution to journal › Review article

14 Scopus citations

Abstract

Atrial fibrillation is a common arrhythmia associated with significant morbidity, including angina, heart failure, and stroke. Medical therapy remains suboptimal, with significant side effects and toxicities, and a high recurrence rate. Catheter ablation or modification of the atrioventricular node with pacemaker implantation provides rate-control but exposes patients to the hazards associated with implantable devices and does nothing to reduce the risk for stroke. Pulmonary vein antrum isolation offers a nonpharmacologic means of restoring sinus rhythm, thereby eliminating the morbidity of atrial fibrillation and the need for antiarrhythmic drugs.

Original language	English (US)
Pages (from-to)	163-178
Number of pages	16
Journal	Cardiology clinics
Volume	27
Issue number	1
DOIs	https://doi.org/10.1016/j.ccl.2008.09.004
State	Published - Feb 1 2009
Externally published	Yes

Fingerprint

Keywords

Antiarrhythmic drugs
Atrial fibrillation
Atrioventricular node ablation
Catheter ablation
Pulmonary veins
Rate control
Rhythm control

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Cite this

Callahan IV, T. D., Di Biase, L., Horton, R., Sanchez, J., Gallinghouse, J. G., & Natale, A. (2009). Catheter Ablation of Atrial Fibrillation. Cardiology clinics, 27(1), 163-178. https://doi.org/10.1016/j.ccl.2008.09.004

@article{7ce9f821eaf4435e80f92d117d59d17b,

title = "Catheter Ablation of Atrial Fibrillation",

abstract = "Atrial fibrillation is a common arrhythmia associated with significant morbidity, including angina, heart failure, and stroke. Medical therapy remains suboptimal, with significant side effects and toxicities, and a high recurrence rate. Catheter ablation or modification of the atrioventricular node with pacemaker implantation provides rate-control but exposes patients to the hazards associated with implantable devices and does nothing to reduce the risk for stroke. Pulmonary vein antrum isolation offers a nonpharmacologic means of restoring sinus rhythm, thereby eliminating the morbidity of atrial fibrillation and the need for antiarrhythmic drugs.",

keywords = "Antiarrhythmic drugs, Atrial fibrillation, Atrioventricular node ablation, Catheter ablation, Pulmonary veins, Rate control, Rhythm control",

author = "{Callahan IV}, {Thomas D.} and {Di Biase}, Luigi and Rodney Horton and Javier Sanchez and Gallinghouse, {Joseph G.} and Andrea Natale",

year = "2009",

month = feb

day = "1",

doi = "10.1016/j.ccl.2008.09.004",

language = "English (US)",

volume = "27",

pages = "163--178",

journal = "Cardiology Clinics",

issn = "0733-8651",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Catheter Ablation of Atrial Fibrillation

AU - Callahan IV, Thomas D.

AU - Di Biase, Luigi

AU - Horton, Rodney

AU - Sanchez, Javier

AU - Gallinghouse, Joseph G.

AU - Natale, Andrea

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Atrial fibrillation is a common arrhythmia associated with significant morbidity, including angina, heart failure, and stroke. Medical therapy remains suboptimal, with significant side effects and toxicities, and a high recurrence rate. Catheter ablation or modification of the atrioventricular node with pacemaker implantation provides rate-control but exposes patients to the hazards associated with implantable devices and does nothing to reduce the risk for stroke. Pulmonary vein antrum isolation offers a nonpharmacologic means of restoring sinus rhythm, thereby eliminating the morbidity of atrial fibrillation and the need for antiarrhythmic drugs.

AB - Atrial fibrillation is a common arrhythmia associated with significant morbidity, including angina, heart failure, and stroke. Medical therapy remains suboptimal, with significant side effects and toxicities, and a high recurrence rate. Catheter ablation or modification of the atrioventricular node with pacemaker implantation provides rate-control but exposes patients to the hazards associated with implantable devices and does nothing to reduce the risk for stroke. Pulmonary vein antrum isolation offers a nonpharmacologic means of restoring sinus rhythm, thereby eliminating the morbidity of atrial fibrillation and the need for antiarrhythmic drugs.

KW - Antiarrhythmic drugs

KW - Atrial fibrillation

KW - Atrioventricular node ablation

KW - Catheter ablation

KW - Pulmonary veins

KW - Rate control

KW - Rhythm control

UR - http://www.scopus.com/inward/record.url?scp=57949110068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57949110068&partnerID=8YFLogxK

U2 - 10.1016/j.ccl.2008.09.004

DO - 10.1016/j.ccl.2008.09.004

M3 - Review article

C2 - 19111772

AN - SCOPUS:57949110068

VL - 27

SP - 163

EP - 178

JO - Cardiology Clinics

JF - Cardiology Clinics

SN - 0733-8651

IS - 1

ER -

Access to Document

10.1016/j.ccl.2008.09.004